Yatharth Hospital & Trauma Care Services Ltd

- There is no mention of any current or planned new fundraising through debt or equity in the transcript. - The company has highlighted a strong balance sheet with a net cash position of approximately INR 284 crores. - The acquisition of the Faridabad hospital is being funded through internal resources (corporate reserves and existing cash) without raising new debt. - The company reported a significant reduction in finance costs due to prudent financial management and lower borrowing expenses. - No statements indicate plans for issuing equity or raising additional debt for ongoing or future expansions. - The focus remains on organic and inorganic expansion financed through existing cash reserves and internal accruals.

- Acquisition of Asian Fidelis Hospital (200-bed super specialty hospital in Faridabad) for INR 1,160 million, expected to complete by March 2024; hospital ready to be operationalized immediately. - Brownfield expansion plans: - Greater Noida Hospital bed capacity to increase from 400 to 600 beds. - Noida Extension Hospital bed capacity to increase from 450 to 700 beds. - Acquired land parcels adjacent to both Greater Noida and Noida Extension hospitals for expansion. - Expected capex per bed for expansions around INR 70 lakhs. - Construction/ramp-up to commence soon, with weather improvement in Delhi NCR cited as a factor for starting. - Strategic focus on doubling bed capacity over the next three years through a combination of greenfield and brownfield expansions. - No debt financing planned for the Faridabad acquisition; to be funded from cash reserves and corporate reserves.

- Revenue grew 21% year-on-year in Q3, reflecting robust growth across specialties. - Nine months FY24 revenue increased 31% year-over-year. - Revenue growth driven by higher ARPOB and increased complexity of procedures. - Bed occupancy improved to 52%-53%, expected to rise further with seasonal trends ending. - Oncology revenue surged more than tenfold YoY; gastroenterology, pulmonology, nephrology, urology, and cardiology also posted strong growth. - Expansion plans include doubling bed capacity, especially in Noida Extension and Greater Noida hospitals, to optimize occupancy. - Addition of new specialties such as radiation and robotic surgeries to attract more patients. - Medical tourism focus expected to significantly boost ARPOB and revenues. - Anticipate reaching optimized utilization in newer hospitals within 2-3 years, contributing to volume and revenue growth. - Continued infrastructure upgrades at hospitals to enhance patient experience and competitiveness.

- Revenue growth momentum remains robust; Q3 FY24 revenue increased 21% YoY and 6% QoQ. - EBITDA margins expanded to 27.8% in Q3 FY24, up 160 bps YoY and 123 bps QoQ; margins expected to be sustainable. - Profit after tax increased 39% YoY in Q3 FY24 and 57% YoY in nine months FY24 period. - Occupancy rate improving (52%-55% group level), with individual hospitals like Greater Noida at 65%-70%. - ARPOB (Average Revenue per Occupied Bed) growing steadily at 14% YoY, driven by higher complexity procedures. - Ramp-up of newer hospitals like Jhansi expected to increase margins progressively. - Medical tourism and super-specialty expansion expected to contribute significantly to revenue and margins. - Expansion plans including bed capacity doubling aligned with anticipated capacity optimization within 2-3 years. - EBITDA positive operations expected for new acquisitions and expansions within 2 years, supporting overall profitability.

The transcript provided does not explicitly mention details about the current or expected order book or pending orders for Yatharth Hospitals and Trauma Care Services Limited. The discussion primarily focuses on operational metrics, hospital expansions, occupancy rates, financial performance, and strategic initiatives such as acquisitions and infrastructure upgrades. No specific data or commentary on order books or pending orders is available in the provided pages.